Imetelstat Combinations in Relapsed AML

Clinical trial NCT07320235 · RECRUITING

Trial details

NCT number: NCT07320235
Sponsor: Douglas Tremblay
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Acute Myeloid Leukemia

Start date: 2026-01-02
Primary completion: 2030-06-17
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.